Related Experiment Video
Updated: Jul 9, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Sulfonate chalcone as new class voltage-dependent K+ channel blocker
Oleg V Yarishkin1, Hyung Won Ryu, Jae-Yong Park
1Department of Physiology, School of Medicine and Institute of Health Science, Gyeongsang National University, Jinju 660-701, Republic of Korea.
New sulfonate chalcone derivatives were synthesized and tested for their ability to block voltage-dependent potassium channels. Chalcone 17 demonstrated the most potent potassium channel blocking activity, showing promise for further research.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Ion Channel Modulation
Background:
- Voltage-dependent potassium (K+) channels play crucial roles in cellular electrophysiology.
- Dysfunction of K+ channels is implicated in various diseases, necessitating the development of specific modulators.
- Chalcone derivatives are a versatile scaffold with diverse biological activities.
Purpose of the Study:
- To synthesize a novel series of chalcone derivatives.
- To investigate the inhibitory activity of these derivatives on voltage-dependent K+ channels.
- To identify potent K+ channel blockers for potential therapeutic applications.
Main Methods:
- Synthesis of 17 chalcone derivatives.
- Electrophysiological assays to measure voltage-dependent K+ channel inhibitory activity.
- Structure-activity relationship analysis to identify key structural features for potency.
Main Results:
- Sulfonate chalcones, specifically those with the sulfonyloxy group on the A-ring (compounds 9-17), exhibited significant K+ channel inhibitory activity.
- Compound 17, 3'-(p-aminobenzene-sulfonylhydroxy)-4-hydroxychalcone, was identified as the most potent blocker.
- Compound 17 showed a potent IC50 value of 0.51+/-0.05 microM.
Conclusions:
- Chalcone derivatives, particularly sulfonate-containing analogs, are effective inhibitors of voltage-dependent K+ channels.
- The position of the sulfonyloxy group on the A-ring is critical for potent activity.
- Compound 17 represents a promising lead compound for the development of novel K+ channel modulators.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

